Your browser doesn't support javascript.
loading
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists.
Zacharia, Athina; Harberts, Erin; Valencia, Sarah M; Myers, Breana; Sanders, Chelsea; Jain, Akshay; Larson, Nicholas R; Middaugh, C Russell; Picking, William D; Difilippantonio, Simone; Kirnbauer, Reinhard; Roden, Richard B; Pinto, Ligia A; Shoemaker, Robert H; Ernst, Robert K; Marshall, Jason D.
Afiliación
  • Zacharia A; Cancer ImmunoPrevention Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Harberts E; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, MD, USA.
  • Valencia SM; Cancer ImmunoPrevention Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Myers B; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Sanders C; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Jain A; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS, USA.
  • Larson NR; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS, USA.
  • Middaugh CR; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS, USA.
  • Picking WD; Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS, USA.
  • Difilippantonio S; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Kirnbauer R; Laboratory of Viral Oncology (LVO), Department of Dermatology, Medical University of Vienna, Austria, EU.
  • Roden RB; Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.
  • Pinto LA; HPV Immunology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Shoemaker RH; Chemopreventive Agent Development Group, Division of Cancer Prevention, NCI, Bethesda, MD, USA.
  • Ernst RK; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, MD, USA.
  • Marshall JD; Cancer ImmunoPrevention Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. Electronic address: jason.marshall2@nih.gov.
Vaccine ; 39(2): 292-302, 2021 01 08.
Article en En | MEDLINE | ID: mdl-33309485

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Oncogénicas Virales / Infecciones por Papillomavirus / Vacunas contra Papillomavirus / Vacunas de Partículas Similares a Virus Límite: Animals Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Oncogénicas Virales / Infecciones por Papillomavirus / Vacunas contra Papillomavirus / Vacunas de Partículas Similares a Virus Límite: Animals Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos